oxymatrine has been researched along with Chronic Hepatitis B in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Jiang, X; Liu, B; Liu, H; Liu, Y; Xie, L; Zheng, L | 1 |
| Wang, X; Yao, N | 1 |
| Luo, J; Song, WJ; Wu, T; Yao, SK | 1 |
| He, XX; Huang, YL; Kuang, ZY; Liu, GJ; Sun, YH; Wang, J; Xie, WQ; Zhang, GX; Zhang, R; Zhang, XY | 1 |
| Liang, JX; Qu, XF; Wei, JJ; Zeng, WT; Zhang, H; Zhu, KL | 1 |
| Cen, S; Chen, HS; Han, YX; Jiang, JD; Li, YH; Liu, F; Peng, ZG; Ren, G; Wang, YP; Xue, R; Zhao, W; Zhou, ZX | 1 |
| Chen, HK; Gu, XB; Hua, Z; Jiang, YM; Lu, ZH; Pei, H; Wu, HY; Yang, XJ; Zhang, B; Zhu, YF | 1 |
| Guo, SH; Guo, YB; Wang, CQ; Wang, QH; Xu, DZ; Yu, YY; Zhang, LX; Zhang, QB; Zhou, XQ; Zhu, LM | 1 |
| Chen, YX; Jiang, JH; Mao, BY | 1 |
| Cai, X; Chen, CW; Chen, WX; Fu, QC; Li, CZ; Li, JQ; Lu, LG; Mao, YM; She, WM; Tang, MF; Wan, MB; Wang, H; Wang, JY; Wu, SM; Ye, J; Zeng, MD; Zhang, HQ; Zhou, XQ; Zhu, JS | 1 |
| Cao, AP; Fang, JY; Lu, LG; Mao, YM; Shen, ZH; Song, YL; Zeng, MD | 1 |
| Cheng, YQ; Fu, JL; Lan, Y; Li, HW; Lou, M; Zhao, P | 1 |
| Cai, X; Chen, CW; Chen, WX; Fu, QC; Li, CZ; Lu, LG; Mao, YM; She, WM; Tang, MF; Wan, MB; Wang, H; Wang, JY; Wu, SM; Ye, J; Zeng, MD; Zhou, XQ; Zhu, JS | 1 |
| Huang, Z; Qiao, G; Si, C; Wang, Q; Yu, Y; Zeng, Z; Zhang, L; Zhang, Q; Zhou, X | 1 |
| He, JF; Liu, J; Shi, BN | 1 |
| Cheng, Y; Fu, HJ; Ping, J; Xu, HD; Zhou, ZH | 1 |
| Shen, BS; Song, XW | 1 |
1 review(s) available for oxymatrine and Chronic Hepatitis B
| Article | Year |
|---|---|
Oral oxymatrine preparation for chronic hepatitis B: A systematic review of randomized controlled trials.
Topics: Administration, Oral; Alkaloids; Hepatitis B, Chronic; Humans; Publication Bias; Quinolizines; Randomized Controlled Trials as Topic | 2016 |
9 trial(s) available for oxymatrine and Chronic Hepatitis B
| Article | Year |
|---|---|
[Mechanism of oxymatrine in preventing hepatic fibrosis formation in patients with chronic hepatitis B].
Topics: Adult; Alkaloids; Female; Hepatitis B, Chronic; Humans; Interleukin-10; Liver Cirrhosis; Male; Middle Aged; Quinolizines; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2010 |
Effect of oxymatrine on specific cytotoxic T lymphocyte surface programmed death receptor-1 expression in patients with chronic hepatitis B.
Topics: Adult; Alkaloids; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Programmed Cell Death 1 Receptor; Quinolizines; T-Lymphocytes, Cytotoxic | 2012 |
[A clinical research on oxymatrine for the treatment of chronic hepatitis B].
Topics: Adolescent; Adult; Alkaloids; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Male; Middle Aged; Quinolizines | 2002 |
[Relationship between serum load of HBV-DNA and therapeutic effect of oxymatrine in patients with chronic hepatitis B].
Topics: Adult; Alkaloids; Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Intramuscular; Male; Middle Aged; Polymerase Chain Reaction; Quinolizines | 2002 |
Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.
Topics: Administration, Oral; Alanine Transaminase; Alkaloids; Antiviral Agents; Double-Blind Method; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Injections, Intramuscular; Placebos; Quinolizines; Treatment Outcome | 2003 |
[IFN or oxymatrine in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B].
Topics: Adult; Alkaloids; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Quinolizines; Recombinant Proteins; Treatment Outcome | 2004 |
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial].
Topics: Adolescent; Adult; Aged; Alkaloids; Antiviral Agents; Double-Blind Method; Female; Hepatitis B, Chronic; Humans; Male; Middle Aged; Quinolizines | 2004 |
[A clinical trial of oxymatrine in treating chronic viral hepatitis type B].
Topics: Adolescent; Adult; Aged; Alkaloids; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Male; Middle Aged; Quinolizines | 2001 |
[Effects of oxymatrine on serum cytokines and hepatic fibrotic indexes in patients with chronic hepatitis B].
Topics: Adolescent; Adult; Alkaloids; Antiviral Agents; Cytokines; Female; Hepatitis B, Chronic; Humans; Interleukin-6; Liver Cirrhosis; Male; Middle Aged; Quinolizines; Transforming Growth Factor beta1; Treatment Outcome | 2008 |
7 other study(ies) available for oxymatrine and Chronic Hepatitis B
| Article | Year |
|---|---|
Oral oxymatrine for hepatitis B cirrhosis: A systematic review protocol.
Topics: Administration, Oral; Alkaloids; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Meta-Analysis as Topic; Protective Agents; Quinolizines; Systematic Reviews as Topic | 2018 |
In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B.
Topics: Alkaloids; Cells, Cultured; Cytokines; Hepatitis B, Chronic; Humans; Immunologic Factors; Ligands; Lymphocytes; Plant Extracts; Quinolizines; Signal Transduction; Sophora; Toll-Like Receptor 9 | 2014 |
Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen.
Topics: Alkaloids; Bacteriophage T7; Carrier Proteins; Hepatitis B, Chronic; Humans; Protein Binding; Quinolizines; Sophora | 2016 |
Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance.
Topics: Administration, Oral; Adult; Alkaloids; Antiviral Agents; Biopsy; China; DNA, Viral; Down-Regulation; Drug Resistance; Drug Therapy, Combination; Female; Gene Expression Profiling; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HSC70 Heat-Shock Proteins; Humans; Lamivudine; Liver; Male; Middle Aged; Quinolizines; Treatment Outcome; Viral Load | 2011 |
Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice.
Topics: Alkaloids; Animals; Antiviral Agents; DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; Mice; Mice, Inbred ICR; Mice, Transgenic; Quinolizines; Virus Integration; Virus Replication | 2004 |
[Effect of oxymatrine on serum matrix metalloproteinase-2 and its inhibitor in patients with chronic hepatitis B and liver cirrhosis].
Topics: Adolescent; Adult; Aged; Alkaloids; Collagen Type IV; Female; Hepatitis B, Chronic; Humans; Hyaluronic Acid; Laminin; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Middle Aged; Quinolizines; Sophora; Tissue Inhibitor of Metalloproteinase-2 | 2005 |
Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro.
Topics: Actins; Alkaloids; Anti-Infective Agents; Antiviral Agents; Collagen Type I; Drug Synergism; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Flavonoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver; Quinolizines | 2006 |